|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance of $14 and $15 | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Long-term assets | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation of $2,208 and $2,126 | ||||||||||||||||||||
| Operating lease assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net of accumulated amortization of $805 and $781 | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Current debt | ||||||||||||||||||||
| Current operating lease liabilities | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Common Stock, $0.01 par value per share; 300,000 shares authorized, 120,458 and 119,868 shares issued and 114,770 and 114,512 shares outstanding, respectively | ||||||||||||||||||||
| Treasury stock, at cost; 5,688 and 5,356 shares, respectively | ||||||||||||||||||||
| Preferred Stock, $0.01 par value per share; 10,000 shares authorized, 0 issued and outstanding | ||||||||||||||||||||
| Additional Paid-In Capital (“APIC”) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated Other Comprehensive Income (Loss) (“AOCIL”) | ||||||||||||||||||||
| Total stockholders’ equity before NCI | ||||||||||||||||||||
| NCI | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
